Connection

MIHAIL CHELU to Humans

This is a "connection" page, showing publications MIHAIL CHELU has written about Humans.
Connection Strength

0.667
  1. Woman With a Pacemaker. Ann Emerg Med. 2024 Aug; 84(2):195-197.
    View in: PubMed
    Score: 0.026
  2. Mortality in Recipients of Durable Left Ventricular Assist Devices Undergoing Ventricular Tachycardia Ablation. JACC Clin Electrophysiol. 2024 Sep; 10(9):2049-2058.
    View in: PubMed
    Score: 0.026
  3. Cardiac conduction diseases: understanding the molecular mechanisms to uncover targets for future treatments. Expert Opin Ther Targets. 2024 May; 28(5):385-400.
    View in: PubMed
    Score: 0.025
  4. Electronic ventricular pacing at the end of the QRS complex: Is it abnormal? J Electrocardiol. 2024 May-Jun; 84:15-16.
    View in: PubMed
    Score: 0.025
  5. Established and Emerging Device Therapy in Heart Failure: Cardiac Contractility Modulation. Tex Heart Inst J. 2023 11 02; 50(6).
    View in: PubMed
    Score: 0.025
  6. Comparison of Ablation Strategies for Persistent Atrial Fibrillation: A Post Hoc Analysis of the DECAAF II Study. Circ Arrhythm Electrophysiol. 2023 10; 16(10):e011975.
    View in: PubMed
    Score: 0.024
  7. Clinical outcomes of conduction system pacing versus biventricular pacing for cardiac resynchronization therapy: A systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2023 08; 34(8):1718-1729.
    View in: PubMed
    Score: 0.024
  8. Detection of atrial fibrillation in real world setting in patients with cryptogenic stroke and an implantable loop recorder. Pacing Clin Electrophysiol. 2023 07; 46(7):788-795.
    View in: PubMed
    Score: 0.024
  9. Conduction System Pacing for Cardiac Resynchronization Therapy: The 31-Million-Dollar Question. Tex Heart Inst J. 2023 05 01; 50(3).
    View in: PubMed
    Score: 0.024
  10. Comparison of cryoballoon and radiofrequency ablation for persistent atrial fibrillation: a systematic review and meta-analysis. J Interv Card Electrophysiol. 2023 Apr; 66(3):585-595.
    View in: PubMed
    Score: 0.023
  11. Innovations in ventricular tachycardia ablation. J Interv Card Electrophysiol. 2023 Sep; 66(6):1499-1518.
    View in: PubMed
    Score: 0.022
  12. Innovations in atrial fibrillation ablation. J Interv Card Electrophysiol. 2023 Apr; 66(3):737-756.
    View in: PubMed
    Score: 0.022
  13. Inherited Arrhythmia Syndromes. Tex Heart Inst J. 2021 Sep 01; 48(4).
    View in: PubMed
    Score: 0.021
  14. Late Gadolinium Enhancement Magnetic Resonance Imaging Evaluation of Post-Atrial Fibrillation Ablation Esophageal Thermal Injury Across the Spectrum of Severity. J Am Heart Assoc. 2021 04 06; 10(7):e018924.
    View in: PubMed
    Score: 0.020
  15. Innovations in Cardiac Implantable Electronic Devices. Cardiovasc Drugs Ther. 2022 08; 36(4):763-775.
    View in: PubMed
    Score: 0.020
  16. Cardiac MRI and Fibrosis Quantification. Card Electrophysiol Clin. 2019 09; 11(3):537-549.
    View in: PubMed
    Score: 0.018
  17. Ablation of atrial fibrillation in patients with heart failure deserves more than a IIb guidelines recommendation. J Cardiovasc Electrophysiol. 2019 09; 30(9):1412-1415.
    View in: PubMed
    Score: 0.018
  18. Atrial Fibrosis by Late Gadolinium Enhancement Magnetic Resonance Imaging and Catheter Ablation of Atrial Fibrillation: 5-Year Follow-Up Data. J Am Heart Assoc. 2018 12 04; 7(23):e006313.
    View in: PubMed
    Score: 0.017
  19. High-Power Radiofrequency Catheter?Ablation of Atrial Fibrillation: Using Late Gadolinium Enhancement Magnetic Resonance Imaging as a Novel?Index?of?Esophageal Injury. JACC Clin Electrophysiol. 2018 12; 4(12):1583-1594.
    View in: PubMed
    Score: 0.017
  20. "Sorting" SERCA2a: A novel therapeutic strategy in heart failure? Int J Cardiol. 2018 12 01; 272:306-307.
    View in: PubMed
    Score: 0.017
  21. Biomarkers (plasma trimethylamine-N-oxide) to predict atrial fibrillation: Are we there yet? Int J Cardiol. 2018 09 15; 267:116-117.
    View in: PubMed
    Score: 0.017
  22. Durable lesion formation while avoiding esophageal injury during ablation of atrial fibrillation: Lessons learned from late gadolinium MR imaging. J Cardiovasc Electrophysiol. 2018 03; 29(3):385-392.
    View in: PubMed
    Score: 0.016
  23. Implantable Cardioverter-Defibrillator Shock after Stenting Across the Device Leads. Tex Heart Inst J. 2016 Feb; 43(1):88-90.
    View in: PubMed
    Score: 0.014
  24. Occasional dropped ventricular pacing in a patient with no underlying rhythm and an Advisa? dual-chamber pacemaker. Europace. 2015 Aug; 17(8):1250.
    View in: PubMed
    Score: 0.014
  25. Incidence of arrhythmias during dialysis in intensive-care-unit patients with end-stage renal disease. Int J Cardiol. 2014 Jul 01; 174(3):753-4.
    View in: PubMed
    Score: 0.013
  26. Fatigue attributable to broken pacemaker header by baseball. Circ Arrhythm Electrophysiol. 2013 Oct; 6(5):e77.
    View in: PubMed
    Score: 0.012
  27. Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice. J Clin Invest. 2009 Jul; 119(7):1940-51.
    View in: PubMed
    Score: 0.009
  28. Sarcoplasmic reticulum calcium leak and cardiac arrhythmias. Biochem Soc Trans. 2007 Nov; 35(Pt 5):952-6.
    View in: PubMed
    Score: 0.008
  29. Atrial Fibrillation in Young Patients: Insights From the National Inpatient Sample. Pacing Clin Electrophysiol. 2024 Dec; 47(12):1688-1697.
    View in: PubMed
    Score: 0.007
  30. Regulation of ryanodine receptors by FK506 binding proteins. Trends Cardiovasc Med. 2004 Aug; 14(6):227-34.
    View in: PubMed
    Score: 0.006
  31. Comprehensive atrial fibrillation burden and symptom reduction post-ablation: insights from DECAAF II. Europace. 2024 May 02; 26(5).
    View in: PubMed
    Score: 0.006
  32. Association between neighborhood household income and inpatient atrial fibrillation outcomes. Heart Rhythm. 2024 07; 21(7):993-1000.
    View in: PubMed
    Score: 0.006
  33. Dapagliflozin for Atrial Fibrillation. Cardiovasc Drugs Ther. 2024 Feb; 38(1):1-3.
    View in: PubMed
    Score: 0.006
  34. Arrhythmic Risk in Biventricular Pacing Compared With Left Bundle Branch Area Pacing: Results From the I-CLAS Study. Circulation. 2024 01 30; 149(5):379-390.
    View in: PubMed
    Score: 0.006
  35. Smartphone AF Burden During the Blanking Period Predicts Catheter Ablation Outcomes: Insights From DECAAF II. JACC Clin Electrophysiol. 2023 10; 9(10):2085-2095.
    View in: PubMed
    Score: 0.006
  36. Sex-Specific Outcomes of LBBAP Versus?Biventricular Pacing: Results From I-CLAS. JACC Clin Electrophysiol. 2024 01; 10(1):96-105.
    View in: PubMed
    Score: 0.006
  37. Comparison of Left Bundle Branch Area?Pacing and Biventricular Pacing?in?Candidates for Resynchronization Therapy. J Am Coll Cardiol. 2023 07 18; 82(3):228-241.
    View in: PubMed
    Score: 0.006
  38. Catheter ablation improved ejection fraction in persistent AF patients: a DECAAF-II sub analysis. Europace. 2023 03 30; 25(3):889-895.
    View in: PubMed
    Score: 0.006
  39. Is it a true left bundle branch block or not? J Interv Card Electrophysiol. 2023 09; 66(6):1329-1331.
    View in: PubMed
    Score: 0.006
  40. Sinus node dysfunction: current understanding and future directions. Am J Physiol Heart Circ Physiol. 2023 03 01; 324(3):H259-H278.
    View in: PubMed
    Score: 0.006
  41. Clinical outcomes and predictors of complications in patients undergoing leadless pacemaker implantation. Heart Rhythm. 2022 08; 19(8):1289-1296.
    View in: PubMed
    Score: 0.006
  42. A Unique Association: Maffucci Syndrome and Cardiac Pathology Anatol J Cardiol. 2022 04; 26(4):331-335.
    View in: PubMed
    Score: 0.005
  43. Genetic testing in ambulatory cardiology clinics reveals high rate of findings with clinical management implications. Genet Med. 2021 12; 23(12):2404-2414.
    View in: PubMed
    Score: 0.005
  44. NLRP3 inflammasome is a key driver of obesity-induced atrial arrhythmias. Cardiovasc Res. 2021 06 16; 117(7):1746-1759.
    View in: PubMed
    Score: 0.005
  45. Genetics of atrial fibrillation. Curr Opin Cardiol. 2021 05 01; 36(3):281-287.
    View in: PubMed
    Score: 0.005
  46. Left atrial fibrosis progression detected by LGE-MRI after ablation of atrial fibrillation. Pacing Clin Electrophysiol. 2020 04; 43(4):402-411.
    View in: PubMed
    Score: 0.005
  47. Systematic collection of patient-reported outcomes in atrial fibrillation: feasibility and initial results of the Utah mEVAL AF programme. Europace. 2020 03 01; 22(3):368-374.
    View in: PubMed
    Score: 0.005
  48. Left atrial functional and structural changes associated with ablation of atrial fibrillation - Cardiac magnetic resonance study. Int J Cardiol. 2020 04 15; 305:154-160.
    View in: PubMed
    Score: 0.005
  49. Left Atrial Fibrosis and Risk of Cerebrovascular and Cardiovascular Events in Patients With?Atrial Fibrillation. J Am Coll Cardiol. 2017 Sep 12; 70(11):1311-1321.
    View in: PubMed
    Score: 0.004
  50. Safety and effectiveness of compassionate use of LARIAT? device for epicardial ligation of anatomically complex left atrial appendages. J Interv Card Electrophysiol. 2015 Jan; 42(1):11-9.
    View in: PubMed
    Score: 0.003
  51. Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation. Am J Cardiol. 2013 Mar 15; 111(6):869-73.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.